Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Aug 16, 2019
Date Accepted: Apr 28, 2020

The final, peer-reviewed published version of this preprint can be found here:

Users’ Experiences of a Mobile Health Self-Management Approach for the Treatment of Cystic Fibrosis: Mixed Methods Study

Floch J, Vilarinho T, Zettl A, Ibañez Sanchez G, Calvo-Lerma J, Stav E, Haro PH, Fides Valero Ă, Bayo-Monton JL

Users’ Experiences of a Mobile Health Self-Management Approach for the Treatment of Cystic Fibrosis: Mixed Methods Study

JMIR Mhealth Uhealth 2020;8(7):e15896

DOI: 10.2196/15896

PMID: 32673237

PMCID: 7381063

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

User Experience of a mHealth Self-Management Approach for the Treatment of Cystic Fibrosis

  • Jacqueline Floch; 
  • Thomas Vilarinho; 
  • Annabel Zettl; 
  • Gema Ibañez Sanchez; 
  • Joaquin Calvo-Lerma; 
  • Erlend Stav; 
  • Peter Halland Haro; 
  • Álvaro Fides Valero; 
  • Jose-Luis Bayo-Monton

ABSTRACT

Background:

Despite a large number of clinical trials aiming at evaluating the usage of digital technology for the self-management of chronic diseases, there is little discussion about the user experience when using this technology. Not surprisingly, evaluations focus on the primary outcomes, i.e., the health outcomes. A good user experience is however a critical factor for retaining patients and health care professionals in using the digital solutions. Understanding the user experience can inform the design of digital solutions towards increased motivation to self-management.

Objective:

Our research relates to the self-management of cystic fibrosis (CF) with focus on the care of young patients. Self-management enfolds the idea that patients in close collaboration with health care professionals gain knowledge about the chronic disease and its treatment, and that they can carry out the necessary steps of the treatment themselves. Therefore, our research targets those directly affected by CF, the parents involved in the treatment and the health care professionals (HCPs). Following a User-Centred Design approach, we have developed digital support for the self-management with focus on gastro-intestinal (GI) concerns. The solution consists of a mobile app for patients and parents, and a professional web tool for HCPs. In order to evaluate this solution, a 6-months clinical trial was conducted in five European countries. This paper analyses the user experience of the patients, parents and HCPs involved in the trial. It addresses two main questions. The first relates to user acceptance: How do the software features and the context of use affect the user experience of the proposed digital self-management approach? The second relates to impact: What are the perceived benefits and downsides of using this digital self-management approach?

Methods:

A mixed methods approach combining qualitative and quantitative data collection was applied to explore the research questions. Data were collected through 42 semi-structured qualitative interviews involving patients, parents and HCPs in six CF competence centres in five European countries. Additionally, data of patients and parents were collected through questionnaires embedded in the self-management app.

Results:

The results show that the enzyme dose calculation and nutrition management features provided by the app are particularly useful. Several benefits were reported, including reduced occurrence of symptoms, increased self-efficacy and enhanced quality of life. Food recording required by the enzyme dose calculation and nutrition management is however sometimes experienced as time consuming and cumbersome. Patients and parents have different skills and the approach requires the follow-up by HCPs, especially in an introductory phase. As the enzyme dose calculation is a novel method introduced by MyCyFAPP, there is still need for improvement. In particular the calculation has to be tailored to personal needs and guidelines for this tailoring have to be developed. From the HCPs perspective, the approach provides more precise information about the patients, thus allowing for more personalized advice. However, patient motivation and quality of recorded data decrease over time as self-efficacy increases, and the tight follow-up of several patients over time leads to an increased work-load of HCPs. We have therefore identified a set of use cases that take into account the factors motivating for app usage and reducing the work-load of HCPs.

Conclusions:

The proposed self-management approach enables patients and parents to rapidly strengthen knowledge about the implementation of the treatment and to increase self-efficacy. There is therefore no need for regular app usage over long time. Rather, identifying for which target groups and in which situations the app is beneficial is more relevant. Digital self-management is a new practice for HCPs. It requires guidelines for implementing new forms of collaboration with patients as well as for the development of new skills for HCPs in order to introduce the digital approach to patients. In particular, there is a need for personalising the follow-up, depending on the patients’ capabilities. Patients develop best practices that have the potential to make the app usage more efficient and effective. These should be collected and shared among patients.


 Citation

Please cite as:

Floch J, Vilarinho T, Zettl A, Ibañez Sanchez G, Calvo-Lerma J, Stav E, Haro PH, Fides Valero Ă, Bayo-Monton JL

Users’ Experiences of a Mobile Health Self-Management Approach for the Treatment of Cystic Fibrosis: Mixed Methods Study

JMIR Mhealth Uhealth 2020;8(7):e15896

DOI: 10.2196/15896

PMID: 32673237

PMCID: 7381063

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.